Short Interest in Check-Cap Ltd. (NASDAQ:CHEK) Drops By 27.5%

Check-Cap Ltd. (NASDAQ:CHEK) saw a significant decrease in short interest during the month of February. As of February 15th, there was short interest totalling 116,000 shares, a decrease of 27.5% from the January 31st total of 159,900 shares. Based on an average daily volume of 1,350,000 shares, the short-interest ratio is presently 0.1 days. Approximately 2.7% of the shares of the stock are sold short.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on shares of Check-Cap in a research report on Saturday. They issued a “sell” rating on the stock.

Check-Cap Trading Down 2.7 %

Shares of NASDAQ CHEK traded down $0.02 during trading on Tuesday, reaching $0.79. The company had a trading volume of 42,968 shares, compared to its average volume of 1,012,975. Check-Cap has a twelve month low of $0.56 and a twelve month high of $3.45. The stock has a 50-day moving average price of $1.11 and a two-hundred day moving average price of $1.23. The stock has a market capitalization of $4.62 million, a PE ratio of -0.26 and a beta of 0.16.

About Check-Cap

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.